Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR TREATING CORONAVIRUS DISEASE, COMPRISING ANTI-ANG2 ANTIBODY, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/005171
Kind Code:
A1
Abstract:
Provided are a composition for treating coronavirus disease, comprising an anti-Ang2 antibody, and a use thereof.

Inventors:
LEE JAE ILE (KR)
LEE YU KYUNG (KR)
KANG SEO KYUNG (KR)
KIM HAN WOOL (KR)
Application Number:
PCT/KR2021/008190
Publication Date:
January 06, 2022
Filing Date:
June 29, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SAMSUNG ELECTRONICS CO LTD (KR)
SAMSUNG BIOEPIS CO LTD (KR)
International Classes:
C07K16/22; A61K39/00; A61P31/14
Foreign References:
KR20150028087A2015-03-13
KR20170076332A2017-07-04
KR20190100060A2019-08-28
Other References:
ANONYMOUS: "Lilly Begins Clinical Testing of Therapies for COVID-19", ELI LILLY AND COMPANY, 10 April 2020 (2020-04-10), XP055883548, Retrieved from the Internet
JEFFREY L. BROWN, Z. ALEXANDER CAO, MARIA PINZON-ORTIZ, JANE KENDREW, CORINNE REIMER, SHENGHUA WEN, JOE Q. ZHOU, MOHAMMAD TABRIZI,: "A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models", MOLECULAR CANCER THERAPEUTICS, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 9, no. 1, 1 January 2010 (2010-01-01), US , pages 145 - 156, XP002639543, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-09-0554
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: